Global Ophthalmic Medicine Market 2020 Size, Market Share, Key Players, Segmentation Development and Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Dec 02, 2020 (CDN Newswire via Comtex) —
The report entitled Global Ophthalmic Medicine Market 2020 by Manufacturers, Type and Application, Forecast to 2025 compiled by MarketQuest.biz presents a new market research analysis that offers a detailed evaluation of the business vertical and a brief overview of the industry segments. The report includes an elemental introduction to the industry, market overview, scope, and product specification. The report aims to target the major images related to market growth, major types, and various end users applicable, regional analysis, productivity structure, current, and future market situation. The report provides a determined perception of the popular market situation that also covers market size in terms of value and volume. Important segment classification of this market includes global Ophthalmic Medicine market-leading players, major geographical regions, product types, and applications.

The report describes the growth of the market such as manufacturers, market size, types, applications, and regions. The report highlights key factors driving and restraining market growth. The research portrays previous and forecasts information in the form of graphical representation. Factors that are encouraging the growth of a specific type of product category and factors that are motivating the status of the market are further included in this report. A comprehensive study of the market is done to recognize the several applications of the features of products and usage.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT:https://www.marketquest.biz/sample-request/20234

The major players who are leading the market throughout the globe are: Novaliq, Mentholatum, Chengdu Kanghong Pharmaceutical Group, Shenyang Xingqi Pharmaceutical Co.,Ltd., Alcon NV, Zhejiang Shapuaisi Pharmaceutical, Bausch Health, Santen Pharmaceutica

Moreover, the report concentrates on global higher leading business players with their details such as company profiles, product picture and specifications, sales, market share, and association information. Additionally, developing strategies and programs are addressed as well as manufacturing methods and cost formations are included. The research contains an analysis of the strategies of major competitors. Elements such as production capacity, price, demand, supply chain/logistics, profit/loss, material parameters/specifications, and the growth factor have been reviewed in the report.

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including: Anti-fatigue and Dryness, Cataract, Anti-infective

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share, and growth rate of each type, primarily split into: Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

Keeping the regional landscape of the global Ophthalmic Medicine market in mind, this industry is segmented into: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast

Read more

Clinical trials are key to advancing medicine, including COVID-19 vaccine

MIAMI – Registered clinical trials reached record levels in the past year, increasing the demand for people willing to participate, and Miami resident Marilyn Strauss Diaz was eager to join a COVID-19 vaccine trial underway at the University of Miami Health System.

“We can’t depend on a lab rat. We have to have human trials for there to be a successful vaccine, so we have to have humans come forward and be a part of trials,” she said.

“Before COVID, we usually would have a couple of hundred clinical trials here going at the same time at the University of Miami that are focused on a lot of different diseases. With COVID, there was a slowdown and now we’re ramping up again and starting a lot of these studies,” said Dr. Olveen Carassquillo, who is part of the research team.

“COVID has the most urgency. That’s a public health crisis so a lot of research is focused on that, but we have a lot of landmark cancer studies going on with different treatment regimens and prevention studies. We also have a lot of cardiovascular disease, a lot of other studies focused on stroke, on preventing dementia,” Carassquillo added.

And South Florida’s diverse population makes it a major focus of research efforts, something Strauss Diaz is proud to be a part of.

“At the end, it will be beneficial to so many,” she said.

To learn more about clinical trials at the University of Miami Health System go to: https://umiamihealth.org/clinical-trials

Copyright 2020 by WPLG Local10.com – All rights reserved.

Source Article

Read more

Precision medicine key to preventing disease developing later in life, Singapore News & Top Stories

SINGAPORE – An individual’s genes can determine the amount of risk he has of developing life-threatening conditions such as heart disease and in turn allows for early intervention.

This is central to the precision medicine programme here, said Professor Tan Chorh Chuan, the chief health scientist from the Ministry of Health and executive director at the Healthcare Transformation Office.

Prof Tan told a webinar on Wednesday (Nov 25) that the programme looks at the genome sequences of participants to help determine the cumulative risks of different diseases based on their genes.

This can be particularly useful for some complaints like premature heart disease, added Prof Tan, who was joined on the webinar panel by Prudential chief executive Dennis Tan and Health Promotion Board (HPB) CEO Zee Yoong Kang.

The event, which covered a broad range of health topics from diabetes and vaccines to strategies on how to stay healthy, is part of The Straits Times Reset 2021 webinar series. It was sponsored by Prudential and moderated by ST senior health correspondent Salma Khalik.

Prof Tan told the webinar that a condition known as familial hypercholesterolemia is caused when a person has a gene that results in high cholesterol levels at a much younger age. If that gene is present, the individual will have up to 20 times higher risk of heart disease – and at an earlier age.

“And then if we identify somebody, we can also test the family. So these preventive strategies will be part of precision health,” he added.

The HPB is working to make use of the clinical, behavioural and digital data as well as genetic data – with patient consent – to identify those at higher risk to allow for early intervention.

Prudential’s Mr Tan said Singaporeans need not be worried about being part of the programme or be concerned if they find out their genome sequences. Having “bad” genes will not make it harder for them to secure insurance policies, he assured.

Privacy is really important, Mr Tan said, adding that “we (Prudential) are very, very careful about such things”.

He said individuals ultimately have to take charge of their own health and should find out more. He said: “Preventive healthcare is all about them being in the driver’s seat, and going through the whole process of early detection, health screening and all.

“So I think as insurers, we will definitely support them.”

Ms Khalik noted that if a person learns that he is at a high risk of getting a certain disease, it will give him the time and opportunity to act before the ailment takes hold.

Source Article

Read more

Digital Medicine Market Size Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (Market Insight Reports) —
Selbyville, Delaware. Market Study Report LLC: A comprehensive research study on Digital Medicine market added by Market Study Report LLC provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Digital Medicine market in terms of the demand landscape, driving factors and growth strategies adopted by market players.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Medicine market by product type, application, key manufacturers and key regions and countries.

Digital medicine technology is an innovative technological technique that has bridged the gap among the healthcare and digital technology. Due to advancement in health care, scientific medicine is pioneered the concept of digital medicine that aims in supporting individualized medicine by recognizing the biology of a patient via a wireless sensor technology and other technologies related to mobile health. Digital medicine is more privileged than recent medical practice as it is more effective, precise, feasible and well distributed technology. Growing healthcare expenditure, high penetration of smartphones, along with high percentage of population with chronic diseases are the few factor responsible for high CAGR of the market over the forecast period.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2495936/?utm_source=Marketwatchtm.com/&utm_medium=AK

Major market player included in this report are:

2Morrow

Ginger

Akili Interactive

Livongo

AliveCor

WellDoc

Mocacare

Proteus Digital Health Voluntis

Omada Health

Digital Medicine Market outlook: Apart from exploring into the various segments, the report clustered on key Digital Medicine Market trends and sectors that are either driving or averting the growth of the Digital Medicine industry. Growth policies and plans are mentioned likewise as producing processes and cost structures also are analyzed. The Digital Medicine Market industry development trends are studied through both secondary and primary sources. Finally, the feasibility of the latest investment comes is assessed and overall analysis conclusions offered in Digital Medicine market analysis report.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Mobile Health

EMR/EHR

Telehealth

Wireless Health

By Application:

Diabetes

Mental Health

Heart Diseases

Others

Research objectives

To study and analyze the global Digital Medicine market size by key regions/countries, type and application, history data from 2016 to 2017, and forecast to 2026.

To understand the

Read more

Your Teachers May Have Been Key to Your Adult Mental Health | Health News

By Cara Murez, HealthDay Reporter

(HealthDay)

MONDAY, Nov. 2, 2020 (Health Day News) — Great teachers can make a big difference in their students’ long-term health, research shows.

Teenagers who had good, supportive relationships with their teachers became healthier adults, according to a new report.

“This research suggests that improving students’ relationships with teachers could have important, positive and long-lasting effects beyond just academic success,” said study author Jinho Kim. He is an assistant professor of health policy and management at Korea University in Seoul.

“It could also have important health implications in the long run,” Kim said in a news release from the American Psychological Association.

For the study, Kim analyzed data from nearly 20,000 participants in a U.S. health study, including 3,400 pairs of siblings. That study followed participants from seventh grade into early adulthood. The teens answered a variety of questions about whether they had experienced trouble getting along with other students or teachers, and whether their friends or teachers cared about them.

In adulthood, the participants were asked about physical and mental health. The study recorded measures of physical health, including blood pressure and body mass index, an estimate of body fat based on height and weight.

The analysis found that participants who had better relationships with teachers and peers also had better physical and mental health in their mid-20s. When Kim looked at pairs of siblings (as a way to control for family background), only the link between student-teacher relationships and adult health remained significant.

Past research had suggested that teens’ peer relationships could be connected to adult health outcomes, possibly because poor relationships can lead to chronic stress, which raises the risk of future health problems, Kim said. It might be that other factors, including different family backgrounds, contributed both to relationship problems in teens and to poor health in adulthood.

Kim recommended that schools invest in training teachers on how to build warm, supportive relationships with students.

“This is not something that most teachers receive much training in,” he said, “but it should be.”

The findings were published online Oct. 29 in the journal School Psychology.

SOURCE: American Psychological Association, news release, Oct. 29, 2020

Copyright © 2020 HealthDay. All rights reserved.

Source Article

Read more

Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers

Significantly Strengthens Intellectual Property Portfolio and Apabetalone’s Commercial Runway Position Through 2040

BETonMACE Results Show Significant Improvement of Key Markers of Diabetes and Renal Function in the Combination of Apabetalone and SGLT2 inhibitors

CALGARY, Alberta, Nov. 02, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) is pleased to announce today highly significant findings on synergy on improved renal function, as measured by estimated glomerular filtration rate (eGFR), and glucose control, as measured by glycated hemoglobin (HbA1c), when apabetalone is combined with sodium-glucose cotransporter-2 (SGLT2) inhibitors, a leading oral anti-diabetic therapy class. These unexpected findings in the BETonMACE Phase 3 trial resulted in the filing of two additional provisional patent applications, further strengthening Resverlogix’s intellectual property portfolio.

The combination of apabetalone and the SGLT2 inhibitors, in addition to standard of care medicines, resulted in a significant improvement of key renal function marker eGFR compared to SGLT2 inhibitors and placebo (p=0.05). Additionally, a significant reduction of plasma Hb1Ac was also observed in patients receiving the combination of apabetalone and the SGLT2 inhibitors, on top of standard of care treatment, compared to placebo (p<0.001). Details of these findings are planned to be submitted to a leading peer review journal in the near future.

“The robust safety and efficacy demonstrated by the combination of apabetalone and SGLT2 inhibitors greatly assists us in our strategic partnership discussions and significantly enhances our intellectual property portfolio and commercial runway position through 2040,” stated Donald McCaffrey, President and CEO. “These important findings – coupled with the significant MACE reduction effects previously highlighted for this patient group – positions the combination of apabetalone and SGLT2 inhibition as a truly novel approach in the treatment for millions of high-risk diabetes and CKD patients worldwide.”

“Plasma eGFR and Hb1Ac are critical markers used to evaluate renal function and glucose control in high-risk patients with kidney disease and diabetes,” stated Kenneth Lebioda, Senior Vice President of Business & Corporate Development. “Control of these markers play a key role in CVD risk reduction as observed in the BETonMACE study, including heart attack, heart failure and CVD death in these patients. These novel and unexpected findings are now patent protected and allow for Resverlogix to explore additional important indications for the combination of apabetalone and SGLT2 inhibitors with an accelerated path to commercialization.”

About eGFR and CKD

According to the National Kidney Foundation, renal function, as measured by eGFR is the strongest non-invasive way to assess renal function and the stage of chronic kidney disease (CKD) in patients. Using a patient’s blood creatinine level, age, body size and gender, physicians can determine the stage of CKD and the optimal treatment plan to improve the likelihood of reducing kidney disease and associated-disorders progression. In the Global Burden of Disease Study, CKD is estimated to affect nearly 700 million people worldwide, many of them still undiagnosed. CKD and worsening renal function impact several other high-risk patient disease groups, and serves as a comorbidity for diabetes, while also indirectly

Read more

Barcelona Offer Key Updates on Ter Stegen, Umtiti Fitness

Marc-Andre ter Stegen


Getty

Barcelona offered key updates on the fitness of goalkeeper Marc-Andre ter Stegen and center-back Samuel Umtiti on Thursday.

Ter Stegen is yet to feature for Barcelona this season after going under the knife in August to repair a knee injury. However, the Germany international was back in training for the first time on Thursday.

Umtiti also took part in some of the session as he bids to return from knee trouble. The Frenchman is also yet to feature in 2020-21 but is closing in on a comeback.

Barcelona players were back on the training ground on Thursday after an important Champions League win over Juventus in Turin. Ronald Koeman’s side return to action in La Liga on Saturday against Alaves.

Follow the Heavy on Barcelona Facebook page for the latest breaking news, rumors and content!


Ter Stegen Still Key for Barcelona

News Ter Stegen is closing in a return to full fitness will be a big boost for Barcelona fans. The 28-year-old has become a key player for the Catalan giants and is viewed as one of Europe’s best goalkeepers.

Barca recently moved to secure Ter Stegen’s future at the club. The stopper has signed a contract extension at the Camp Nou that runs until 2025. His buyout clause is set at an eye-popping €500 million.

Ter Stegen is expected to slot straight back into the starting XI when fully fit, taking over from deputy Neto. The Brazilian has proven an able back-up in Ter Stegen’s absence but should drop back down to the bench.


Outcast Umtiti Hoping For Second Chance

Meanwhile, Umtiti will be hoping he can force his way into Koeman’s thinking after a tough time with injuries. The Frenchman is no longer a guaranteed starter at the Camp Nou and has slipped way down the pecking order.

Gerard Pique, Clement Lenglet, and 21-year-old Ronald Araujo are now Barca’s first three central defensive options, while Koeman has also been keeping tabs on Barca B defender Oscar Mingueza and included the youngster in his Champions League squad.

Umtiti looks to have his work cut out to play regularly at Barca again, although he did tell Canal Football Club in a recent interview that he is not interested in leaving the Camp Nou, as reported by Sport.

I don’t see myself at any club than Barca. I’ve been pretty clear about that with everyone. Lyon is my club, my city. They were the team that gave me the chance to play in Europe, at Barca and in the national team. There were conversations with Lyon this summer, but there was nothing in concrete. The last two years have been the worst of my career. I’ve never worked so hard. I need to make up for lost time.

Yet the Frenchman could face even more competition for a place in the team

Read more

Atlas push to ‘slow the testing down’ tracks with dramatic decline in one key state

Atlas, a neuroradiologist, not an infectious disease expert, strongly supported a decision in August to revise federal guidelines to de-emphasize the need to test people without symptoms, according to two sources familiar with the process. He shared his view with state officials, including Republican Gov. Ron DeSantis and several others in Florida, according to transcripts of public events and accounts from private meetings in that state.

“The purpose of testing is to stop people from dying,” Atlas said during one stop, captured on video. “When you start introducing closure of schools because people have positive, asymptomatic tests, that’s sort of not the purpose of testing.”   

“I think, Dr. Atlas, we’re in agreement on focusing strategies in school on people who are symptomatic,” DeSantis said in another joint news conference that day. 

Their push to de-emphasize tests coincided with a dramatic drop in testing across Florida, even as the country was careening toward a fall coronavirus surge. A CNN analysis of the Florida state official numbers, aggregated by the Covid Tracking Project, shows that testing dropped off at the end of July and early August, with a peak seven-day average over 90,000 tests per day on July 18. Six weeks later, in early September, the seven-day average dropped by nearly half, with fewer than 48,000 tests per day, and hovered between there and 60,000 during the fall.

If Atlas and DeSantis’ advocacy in Florida is, in fact, responsible for the state’s testing decrease, that would be in keeping with the wishes of Trump, who for months has falsely suggested that the US has so many coronavirus cases only because it conducts so many tests. In June, Trump even said publicly that he wanted to “slow the testing down, please.”   

Though both Atlas and DeSantis declined to discuss their views with CNN for this story, they have articulated them in public. Some state and local officials believe the pair was influential in taking Trump’s anti-testing pronouncements and helping to turn them into public policy. And the drop-off in testing is of deep concern to some. It took place as positivity rates remained high, in the range that the Centers for Disease Control and Prevention considers indicative of high community spread.

Asymptomatic Covid-19 carriers are still contagious, experts say. A lack of widespread testing makes it harder to map the disease as it spreads and to warn those at risk of illness.    

“There’s no question more people are going to die,” says Miami Beach Mayor Dan Gelber, a critic of DeSantis’ approach to testing and other matters of the governor’s pandemic management. “We are flying blind without tests.”    

At the moment, the nation is experiencing another surge of illness. Daily case numbers are reaching levels not seen since late July, and Florida is starting to see its numbers go up as well. Experts say that widespread testing, including of asymptomatic carriers, is critical to limiting the spread of the virus.    

A White House spokesman claimed Atlas had never advocated reducing testing, despite the

Read more

Pence’s Chief of Staff and Other Key Aides Test Positive for Coronavirus

WASHINGTON—Vice President Mike Pence’s chief of staff Marc Short, a campaign adviser and at least three other staffers have tested positive for Covid-19, but with just days left until Election Day, President Trump’s running mate will continue to maintain his schedule.

Mr. Pence, the head of the White House Coronavirus Task Force, considers himself to be a close contact of Mr. Short, who tested positive on Saturday, according to a statement from Pence spokesman Devin O’Malley.

Marty Obst, Mr. Pence’s longtime political adviser, also recently tested positive, according to people familiar with the matter, and at least three additional staff in the vice president’s office have also tested positive, one person familiar with the matter said.

White House chief of staff Mark Meadows said Sunday morning that multiple staffers close to Mr. Pence had tested positive but didn’t identify others beyond Mr. Short by name.

“Marc Short and a couple of key staff around the vice president have come down with the coronavirus,” Mr. Meadows said on CNN. “We certainly wish them the very best.”

The vice president, who tested negative on Saturday along with his wife, has decided not to quarantine, Mr. O’Malley said. Mr. Pence consulted with White House medical staff, and will instead follow guidelines for “essential personnel.” Mr. Pence’s office declined additional comment.

Coronavirus in the White House

According to guidelines from the Centers for Disease Control and Prevention, the close contact of a person infected with Covid-19 should quarantine “even if you test negative” because symptoms may appear 2 to 14 days after exposure to the virus.

Mr. Pence is scheduled to campaign in North Carolina on Sunday and in Minnesota on Monday. Mr. Meadows said that the vice president would take extra precautions as he maintains his schedule, including wearing a mask and social distancing.

“Obviously when you have an exposure, you have to take additional mitigation factors to do that,” he said.

The announcement of the positive tests comes three weeks after President Trump and multiple members of his staff tested positive for coronavirus. Mr. Trump’s infection required a three-night stay in the hospital. He returned to the campaign trail 11 days after his initial positive test.

Katie Miller, Mr. Pence’s press secretary, tested positive for the virus in May. She has since returned to work.

The U.S. added nearly 84,000 coronavirus cases Saturday for the second-straight day. Saturday’s total of 83,718 new cases marked the second-highest single-day count after the record 83,757 infections logged Friday, according to data compiled by Johns Hopkins University. The U.S. has reported nearly 8.58 million infections in total, with the death toll nearing 225,000.

Write to Michael C. Bender at [email protected]

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Source Article

Read more

Key Defender Hands Barcelona Clasico Fitness Boost

Jordi Alba


Getty

Jordi Alba has handed Barcelona a fitness boost ahead of Saturday’s La Liga clash with Real Madrid at the Camp Nou. The left-back returned to training on Thursday after being sidelined with a hamstring injury.

The 31-year-old has not featured since hobbling off in Barcelona’s 1-1 draw with Sevilla, missing the games against Getafe in La Liga and Ferencvaros in the Champions League.

New signing Sergino Dest has filled in for Alba during his absence and has made a strong start to his Barcelona career. The 19-year-old’s preferred position is on the right side of the defense, but he has already shown he’s comfortable on the opposite flank.

Follow the Heavy on Barcelona Facebook page for the latest breaking news, rumors and content!


Will Alba Play?

Alba could now make his return to action against Real Madrid, although there will be a discussion between “the player, Ronald Koeman and the club’s medical staff” as to whether he should feature, according to Marca’s Luis F. Rojo.

The final decision seems set to be made by manager Koeman after the team’s final training session before El Clasico on Friday. Yet the Dutchman won’t want to take any risks, particularly with a crunch Champions League clash against Juventus scheduled for Wednesday.

According to Juan Jimenez at AS, Alba felt good in Thursday’s session, but he’s more likely to appear as a second-half substitute against Real Madrid rather than a starter.

The report also notes how Alba’s injury history suggests Barcelona will take the “utmost caution” with the left-back to avoid any relapse and potentially more time on the sidelines.


Dest or Junior Firpo?

Dest is the most likely option to continue in the Barcelona defense should Alba not be named in Koeman’s starting XI. The teenager has started the club’s last two games and will be hoping to become the first American to play in El Clasico.

The defender has told Voetbal International, as reported by Sport, that he is enjoying the step up and the challenge of playing for Barcelona after his move from Eredivise side Ajax.

People may think that I went to Barcelona too early, that I should have stayed longer at Ajax. When you go to Spain to live there, you learn Spanish earlier and better than if you stayed in the Netherlands. That’s how I see it with football. I think that when I’m in Barcelona I can develop to a certain level faster. It’s a challenge, but I love it.

Dest does face competition for his place now fellow left-back Junior Firpo has returned to fitness after hamstring trouble. The 24-year-old made his first appearance of the season off the bench against Ferencvaros and is an option to come into the team.

Firpo has struggled to make much of an impact at Barcelona since his move to the Camp Nou in summer 2019 but was part of the Real Betis team that

Read more
  • Partner links